Article
Recognition of multiple potential diagnostic biomarkers and therapeutic targets for ovarian serous cystadenocarcinoma (OSOC)
2025-11-12
Abstract excerpt
<title>Abstract</title> <p>Background: Ovarian serous cystadenocarcinoma (OSOC) is the most common gynecologic cancer (GC), but existing therapeutics are limited. Therefore, novel molecular pathways that contribute to OSOC therapy and diagnostics are urgently needed. <h4>Methods:</h4> Based on the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) databases, we acquired differentially expressed gene...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cce38855-80f1-50d1-a7ec-748b19f0a82a
- DOI
- 10.21203/rs.3.rs-7523248/v1
